*Corresponding author:Arleta Waszczykowska, Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland, Tel: 48426393634; Email: email@example.com
Received: February 01, 2018; Published: February 12, 2018
To view the Full Article Peer-reviewed Article PDF
Keratoconusis a progressiveeye disease, whichdiscloses in adolescence and usuallystabilizes in thefourthorfifthdecadeoflife. Theprogressivethinningofcorneal stroma in which the cornea has a conical shapeleads to high irregular a stigmatism and consequently to a significantvisualacuitydecrease. Anymethod to curethediseasehas beendeveloped up to thisday. Corneal collagen cross-linking (CXL) is the first treatment that halts the progression of keratoconus. Cross-linkingconducted in the early stages of keratoconus allows to stop cornealchangesduring early grade, easier to opticalcorrection. From the times of “Dresden Protocol” until now, multiple variations of the standard procedure technique have been introduced and consistent improvement is still being searched for.Not onlydoesthe study presenttheclassicalmethodof CXL, acceleratedand transepithelial CXL modifications, but thelatestresearchabouttheireffectiveness as well.
Keywords: Corneal cross-linking; CXLl; Accelerated cross-linking; High irradiance; Transepithelial cross-linking; Keratoconus